On January 10, 2025, immediately following the success of the SCI TechUpdate 2024 annual scientific conference, the VNUHCM–US Stem Cell Institute (SCI) and Vạn Hạnh General Hospital officially signed a Memorandum of Understanding (MoU) establishing a strategic partnership.

This marks Vạn Hạnh General Hospital as the first official strategic hospital partner of SCI.

A Decade of Collaboration

The partnership between SCI and Vạn Hạnh General Hospital began in 2014, marking ten years of scientific and technological cooperation.

Over the past decade, both institutions have jointly implemented multiple research projects and clinical trials.

SCI has developed and optimized technology-based solutions to address real-world medical needs at Vạn Hạnh Hospital — a collaboration that has led to breakthrough achievements in stem cell science and its clinical applications.

Complementary Strengths, Shared Vision

This partnership connects SCI’s expertise in scientific innovation and advanced technology with Vạn Hạnh Hospital’s extensive clinical experience.

Together, both sides share a common goal: to enhance the quality of patient care and bring stem cell technologies from the laboratory into clinical reality.

In this new phase of collaboration, the focus will be on:

• Professional Training: Upgrading clinical staff competencies and integrating new biomedical technologies.
• Clinical Research: Conducting joint clinical studies on potential disease treatments using stem cells.
• Scientific Publications: Co-authoring international research papers to enhance Viet Nam’s presence in global medical science.

The signing ceremony took place in a solemn and cooperative atmosphere, opening a promising new chapter in Viet Nam’s regenerative medicine development.

With shared vision and commitment, the collaboration between SCI and Vạn Hạnh General Hospital is expected to create tangible contributions to the advancement of biomedical research and clinical innovation in Viet Nam.